ADS VeriChip Marketing Campaign Gets Under FDA’s Skin – Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Applied Digital Solutions' VeriChip subcutaneous, microchip-based information repository could pose minor health risks and likely would be deemed Class II with special controls under Center for Devices & Radiological Health oversight, device center reps suggest